A novel CCR4 antagonist induces potent anti-tumor response through inhibition of Treg migration into the tumor microenvironment

被引：0
|
作者：
Nair, Rashmi
Abbineni, Chandrasekhar
Talluri, Krishna Chaitanya
Dhudashiya, Amit A.
Aravind, A. B.
Kumar, Naveen R.
Ramya, R.
Balasubramanyam, D.
Obanna, Pathur
Madhaiyan, Rabin
Samiulla, D. S.
Daginakatte, Girish
Narayanan, Kishore
Nellore, Kavitha
Chelur, Shekar
Samajdar, Susanta
Ramachandra, Murali
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6537
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6537
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combination of a Novel EP4 Antagonist E7046 and Radiation Therapy Promotes Anti-tumor Immune Response and Tumor Rejection in Preclinical Tumor Models
    Bao, X.
    Albu, D. I.
    Huang, K. C.
    Wu, J.
    Twine, N.
    Nomoto, K.
    Woodall-Jappe, M.
    Ataman, O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S128 - S128
  • [32] Targeting glycosylated PD-1 induces potent anti-tumor immunity
    Wang, Yuhan
    Sun, Linlin
    Yang, Riyao
    Liu, Jielin
    Qiu, Yufan
    Hsu, Jennifer L.
    Cha, Jong-ho
    Chan, Li-Chuan
    Hsu, Jung-Mao
    Lee, Heng-Huan
    Lai, Yun-Ju
    Khoo, Kay-Hooi
    Chung, Ezra M.
    Li, Chia-Wei
    Kim, Yong-Soo
    Park, Andrew H.
    Yang, Yi
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Characteristics of a potent tumor vaccine-induced secondary anti-tumor T cell response
    Mahnke, YD
    Schirrmacher, V
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (06) : 1427 - 1434
  • [34] Semaglutide as a potent activator of anti-tumor immune response in breast cancer
    Stanisavljevic, Isidora
    Jovanovic, Ivan
    Markovic, Bojana Simovic
    Corovic, Irfan
    Krajnovic, Tamara
    Mijatovic, Sanja
    Pavlovic, Sladjana
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 748 - 748
  • [35] Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity
    Abdel-Motal, Ussama M.
    Wigglesworth, Kim
    Galili, Uri
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (10) : 1545 - 1556
  • [36] Intratumoral injection of α-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity
    Ussama M. Abdel-Motal
    Kim Wigglesworth
    Uri Galili
    Cancer Immunology, Immunotherapy, 2009, 58
  • [37] Porcine Treg depletion with a novel diphtheria toxin-based anti-human CCR4 immunotoxin
    Wang, Zhaohui
    Navarro-Alvarez, Nalu
    Shah, Jigesh A.
    Zhang, Huiping
    Huang, Qi
    Zheng, Qian
    Madsen, Joren C.
    Sachs, David H.
    Huang, Christene A.
    Wang, Zhirui
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2016, 182 : 150 - 158
  • [38] EVALUATING THE IMPACT OF CAR DESIGN ON THE TUMOR IMMUNE MICROENVIRONMENT AND ANTI-TUMOR RESPONSE IN SYNGENEIC GLIOMA MODELS
    Haydar, Dalia
    Crawford, Jeremy
    Chou, Ching-Heng
    Guy, Cliff
    Yi, Zhongzhen
    Zoine, Jaquelyn
    Gottschalk, Stephen
    Roussel, Martine
    Thomas, Paul
    Krenciute, Giedre
    NEURO-ONCOLOGY, 2023, 25
  • [39] A Novel Oncolytic Adenovirus Expressing Tumor Microenvironment Stimulators to Evoke and Facilitate Anti-Tumor Immune Responses
    Wenthe, Jessica
    Eriksson, Emma
    Milenova, Ioanna
    Moreno, Rafael
    Alemany, Ramon
    Loskog, Angelica
    MOLECULAR THERAPY, 2016, 24 : S206 - S206
  • [40] Metabolism as checkpoint: Induction of anti-tumor immune response with the novel glutamine antagonist JHU-083
    Leone, Robert D.
    Englert, Judson M.
    Oh, Min-Hee
    Cheng, Chih-Hsien
    Rais, Rana
    Slusher, Barbara
    Powell, Jonathan D.
    CANCER RESEARCH, 2017, 77
12345